"Fibrinolytic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN.
| Descriptor ID |
D005343
|
| MeSH Number(s) |
D27.505.519.421.750 D27.505.954.411.320 D27.505.954.502.427
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fibrinolytic Agents".
Below are MeSH descriptors whose meaning is more specific than "Fibrinolytic Agents".
This graph shows the total number of publications written about "Fibrinolytic Agents" by people in this website by year, and whether "Fibrinolytic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 2 | 3 |
| 1997 | 2 | 0 | 2 |
| 1999 | 7 | 1 | 8 |
| 2000 | 4 | 1 | 5 |
| 2001 | 3 | 0 | 3 |
| 2002 | 3 | 1 | 4 |
| 2003 | 5 | 7 | 12 |
| 2004 | 11 | 2 | 13 |
| 2005 | 7 | 4 | 11 |
| 2006 | 7 | 5 | 12 |
| 2007 | 1 | 8 | 9 |
| 2008 | 11 | 3 | 14 |
| 2009 | 9 | 3 | 12 |
| 2010 | 6 | 5 | 11 |
| 2011 | 0 | 5 | 5 |
| 2012 | 6 | 7 | 13 |
| 2013 | 7 | 5 | 12 |
| 2014 | 15 | 5 | 20 |
| 2015 | 10 | 5 | 15 |
| 2016 | 6 | 1 | 7 |
| 2017 | 6 | 2 | 8 |
| 2018 | 13 | 5 | 18 |
| 2019 | 7 | 6 | 13 |
| 2020 | 3 | 6 | 9 |
| 2021 | 5 | 5 | 10 |
| 2022 | 2 | 4 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fibrinolytic Agents" by people in Profiles.
-
Findings on Repeat Posttraumatic Brain Computed Tomography Scans in Older Patients With Minimal Head Trauma and the Impact of Existing Antithrombotic Use. Ann Emerg Med. 2023 03; 81(3):364-374.
-
Vagus nerve stimulation paired with rehabilitation for stroke: Implantation experience from the VNS-REHAB trial. J Clin Neurosci. 2022 Nov; 105:122-128.
-
Stroke Severity among Men and Women Acute Ischemic Stroke Patients in the Telestroke Network. Cerebrovasc Dis Extra. 2022; 12(2):93-101.
-
Diagnosis and Treatment of Acute Coronary Syndromes: A Review. JAMA. 2022 Feb 15; 327(7):662-675.
-
Endovascular thrombectomy with and without preceding intravenous thrombolysis for treatment of large vessel anterior circulation stroke: A cross-sectional analysis of 50,000 patients. J Neurol Sci. 2022 Mar 15; 434:120168.
-
Acute Ischemic Stroke and Heart Failure: Stroke Risk Factors Associated with Exclusion from Thrombolytic Therapy. Clin Appl Thromb Hemost. 2022 Jan-Dec; 28:10760296221116347.
-
Increased rebleeding and mortality in patients with gastrointestinal bleeding treated with anticoagulant drugs compared to antiplatelet drugs. Eur J Gastroenterol Hepatol. 2021 12 01; 33(1S Suppl 1):e490-e498.
-
Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation. Front Immunol. 2021; 12:785229.
-
Bridging thrombolysis in atrial fibrillation stroke is associated with increased hemorrhagic complications without improved outcomes. J Neurointerv Surg. 2022 Oct; 14(10):979-984.
-
Antithrombotic Therapy after Acute Coronary Syndromes. Reply. N Engl J Med. 2021 05 13; 384(19):1873-1874.